RE:Mr. Market is wrong on this?Whatever is coming down the pipeline is still not being valued. The market is waiting to see how this will all be structured and what it looks like in the end. I think regardless, it goes higher.
From what we know Gilles has always aimed for his ideal partnership and structure, so I am giving him the benefit of the doubt that he will achieve this. However, even if its not the deal we've all dreamt of, it will still very likely be accretive. So this stock in my opnion is clearly undervalued in longer term, especially with growing base business.
I also believe this is an inevitable 10 bagger if we see partnership and BG pill, and there are so many extra feathers in our cap such as Covid-19 therapeutic, and a myriad of other PGX applications.